MedPath

LIVTENCITY

LIVTENCITY

Approved
DIN Number

02530740

Drug Class

Human

Market Date

Oct 25, 2022

Company
HC

takeda canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02530740
AIG Number0164061001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AX10 MARIBAVIR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

MARIBAVIRActive
Strength: 200 MG
Monograph: MARIBAVIR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.